NUCLEAR MEDICINE COMMUNICATIONS, vol.28, no.10, pp.775-781, 2007 (SCI-Expanded)
Objective The aim of this study was to evaluate the use of Tc-99m(V)-dimercaptosuccinic acid (Tc-99m(V)-DMSA) scintigraphy for the assessment of disease activity in patients with Graves' ophthalmopathy (GO) and compare their clinical parameters.